TGFB1 and cardiovascular disorder: The involvement of TGFβ signaling in many cellular processes and its dysregulated expression in many disease states, including cancer, cardiovascular disease and fibrosis have led to the development of multiple drugs that target different components of TGFβ signaling pathways.